{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:25:55Z","timestamp":1769167555711,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1136\/ard.60.12.1081","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:32:19Z","timestamp":1027765939000},"page":"1081-1085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Beh\u00e7et's disease and thrombophilia"],"prefix":"10.1016","volume":"60","author":[{"given":"M","family":"Leiba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Sidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Gur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Leiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ehrenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.12.1081_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0714.1994.tb00063.x","article-title":"The person behind the eponym: Hulusi Beh\u00e7et (1889\u20131948).","volume":"23","author":"Multu","year":"1994","journal-title":"J Oral Pathol Med"},{"key":"10.1136\/ard.60.12.1081_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0190-9622(88)70233-9","article-title":"Beh\u00e7et's disease. New preparation on an enigmatic syndrome.","volume":"19","author":"Arbesfeld","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.60.12.1081_bib3","unstructured":"Koc Y, Gullu I, Akpek G, Akpolat T, Knsu E, Kiraz S, et al. Vascular Involvement in Beh\u00e7et's Disease. J Rheumatol 1992;19:402\u201310."},{"key":"10.1136\/ard.60.12.1081_bib4","doi-asserted-by":"crossref","unstructured":"Gul A, Ozbek U, Ozturk C, Inanc M, Konice M, Ozcelik T, et al. Coagulation factor V gene mutation increases the risk of venous thrombosis in Beh\u00e7et's disease. Br J Rheumatol 1996;35:1178\u201380.","DOI":"10.1093\/rheumatology\/35.11.1178"},{"key":"10.1136\/ard.60.12.1081_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/BF00299119","article-title":"Vascular involvement in Beh\u00e7et's disease: 8 year audit.","volume":"18","author":"Kuzu","year":"1994","journal-title":"World J Surg"},{"key":"10.1136\/ard.60.12.1081_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/096120339700600706","article-title":"Abnormalities in protein C anticoagulant pathway detected by a novel assay using human thrombomodulin.","volume":"6","author":"Mohri","year":"1997","journal-title":"Lupus"},{"key":"10.1136\/ard.60.12.1081_bib7","first-page":"305","article-title":"Von Willebrand factor in Beh\u00e7et's disease.","volume":"14","author":"Yazici","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2165\/00003495-199142050-00006","article-title":"Practical treatment recommendations for pharmacotherapy in Beh\u00e7et's syndrome.","volume":"42","author":"Yazici","year":"1991","journal-title":"Drugs"},{"key":"10.1136\/ard.60.12.1081_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0038-1646768","article-title":"Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.","volume":"59","author":"Pelzer","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.60.12.1081_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/clinchem\/39.4.683","article-title":"Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population.","volume":"39","author":"Hursting","year":"1993","journal-title":"Clin Chem"},{"key":"10.1136\/ard.60.12.1081_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02874109","article-title":"Beh\u00e7et's disease as a prethrombotic state.","volume":"28","author":"Haznedaroglu","year":"1998","journal-title":"Int J Clin Lab Res"},{"key":"10.1136\/ard.60.12.1081_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0609.1996.tb00499.x","article-title":"Haemostatic markers of procoagulant imbalance in Beh\u00e7et's disease.","volume":"57","author":"Haznedaroglu","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1136\/ard.60.12.1081_bib13","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease.","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.60.12.1081_bib14","first-page":"658","article-title":"Beh\u00e7et's disease in Saudi Arabia.","volume":"21","author":"Al-Dalaan","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2214\/ajr.164.1.7998568","article-title":"Thoracic involvement in Beh\u00e7et's disease: pathologic, clinical, and imaging features.","volume":"164","author":"Tunaci","year":"1995","journal-title":"Am J Roentgenol"},{"key":"10.1136\/ard.60.12.1081_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2796.1996.396853000.x","article-title":"Impaired haemostatic kinetics and endothelial function in Beh\u00e7et's disease.","volume":"240","author":"Haznedaroglu","year":"1996","journal-title":"J Intern Med"},{"key":"10.1136\/ard.60.12.1081_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1055\/s-0038-1650405","article-title":"Circulating thrombomodulin as a clue of endothelial damage in Beh\u00e7et's disease.","volume":"75","author":"Haznedaroglu","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.60.12.1081_bib18","first-page":"751","article-title":"Vasculo-Beh\u00e7et's disease: immunological study of the formation of aneurysm.","volume":"29","author":"Yamana","year":"1998","journal-title":"J Cardiovasc Surg"},{"key":"10.1136\/ard.60.12.1081_bib19","first-page":"249","article-title":"Activated protein C resistance in Beh\u00e7et's disease.","volume":"17","author":"Kosar","year":"1988","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.60.12.1081_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2362.1988.tb01032.x","article-title":"Decreased prostacyclin sensitivity of platelets in patients with Beh\u00e7et's syndrome.","volume":"18","author":"Wilson","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1136\/ard.60.12.1081_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.48.7.590","article-title":"Defective fibrinolysis in Beh\u00e7et's syndrome: significance and possible mechanism.","volume":"48","author":"Aitchison","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.12.1081_bib22","first-page":"2103","article-title":"Arterial lesions in Beh\u00e7et's disease. A study in 25 patients.","volume":"22","author":"Le Thi Hong","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib23","series-title":"Beh\u00e7et's disease: basic and clinical aspects.","first-page":"541","article-title":"Coagulation and fibrinolytic activity in Beh\u00e7et's disease.","author":"Chamberlain","year":"1991"},{"key":"10.1136\/ard.60.12.1081_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/ejvs.2000.1091","article-title":"Haemostasis in patients with Beh\u00e7et's disease.","volume":"19","author":"Demirer","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1136\/ard.60.12.1081_bib25","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/ard.54.9.726","article-title":"Lp (a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Beh\u00e7et's disease.","volume":"54","author":"Orem","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.12.1081_bib26","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/S0021-9258(18)52266-3","article-title":"Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cell.","volume":"226","author":"Etingin","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.60.12.1081_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1646409","article-title":"Coagulation and fibrinolytic activity in Beh\u00e7et's disease.","volume":"66","author":"Hampton","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.60.12.1081_bib28","first-page":"206","article-title":"Antithrombin III, protein C and protein S plasma levels in patients with Beh\u00e7et's disease.","volume":"26","author":"Nalcaci","year":"1998","journal-title":"J Med Res"},{"key":"10.1136\/ard.60.12.1081_bib29","first-page":"2404","article-title":"Thrombophilic factors and their relation to thromboembolic and other clinical manifestation in Beh\u00e7et's disease.","volume":"26","author":"Mader","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib30","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s002680010282","article-title":"Comparison of coagulation parameters for healthy subjects and Beh\u00e7et's disease patients with and without vascular involvment.","volume":"24","author":"Neriman","year":"2000","journal-title":"World J Surg"},{"key":"10.1136\/ard.60.12.1081_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01451044","article-title":"Thrombomodulin levels in Beh\u00e7et's disease with and without factor V Leiden mutation.","volume":"17","author":"Guerey","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib32","first-page":"S124","article-title":"Beh\u00e7et's disease, endothelium and thrombosis [abstract].","volume":"43(suppl)","author":"Espinosa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.12.1081_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis.","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.60.12.1081_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in bood coagulation factor V associated with resistance to activated protein C.","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1136\/ard.60.12.1081_bib35","first-page":"2196","article-title":"Association of factors V Leiden with Beh\u00e7et's disease.","volume":"24","author":"Mammo","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib36","first-page":"496","article-title":"Factor V leiden mnutation in patients with Beh\u00e7et's disease.","volume":"25","author":"Oner","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0002-9394(99)00184-1","article-title":"Factor V Leiden mutation is associated with ocular involvement in Beh\u00e7et's disease.","volume":"128","author":"Verity","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1136\/ard.60.12.1081_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/096120339600500505","article-title":"The concept and classification of antiphospholipid\/cofactor syndromes.","volume":"5","author":"Alarcon-Segovia","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.60.12.1081_bib39","first-page":"713","article-title":"Anti-prothrombin but not \u2018pure\u2019 anticardiolipin antibodies are associated with the clinical features of the antiphospholipid antibodies syndrome.","volume":"80","author":"Sorice","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.60.12.1081_bib40","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(98)10362-8","article-title":"Antiphospholipid antibodies and thrombosis.","volume":"353","author":"Greaves","year":"1999","journal-title":"Lancet"},{"key":"10.1136\/ard.60.12.1081_bib41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.1993.tb00172.x","article-title":"Anticardiolipin antibodies in adamantiades - Beh\u00e7et's disease.","volume":"128","author":"Zouboulis","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard.60.12.1081_bib42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/ard.43.5.746","article-title":"Anticardiolipin antibodies: occurrence in Beh\u00e7et's syndrome.","volume":"43","author":"Hull","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.12.1081_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02231554","article-title":"Association of anticardiolipin antibodies with vascular thrombosis and neurological manifestation of Beh\u00e7et's disease.","volume":"12","author":"Al-Daalan","year":"1993","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.60.12.1081_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1346-8138.1990.tb01619.x","article-title":"Anticardiolipin antibodies in Behecet's disease.","volume":"17","author":"Bergman","year":"1990","journal-title":"J Dermatol"},{"key":"10.1136\/ard.60.12.1081_bib45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3928\/1542-8877-19970801-07","article-title":"Anticardiolipin antibodies and retinal vascular complications in Beh\u00e7et's disease.","volume":"28","author":"Odzemir","year":"1997","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1136\/ard.60.12.1081_bib46","first-page":"411","article-title":"Markers of vascular injury in Beh\u00e7et's disease associated with retinal vasculitis.","volume":"24","author":"Pivetti-Pezzi","year":"1992","journal-title":"Ann Ophthalmol"},{"key":"10.1136\/ard.60.12.1081_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0037-1613776","article-title":"Is there a role for antiphospholipid binding protein antibodies in the pathogenesis of thrombosis in Beh\u00e7et's disease?","volume":"83","author":"Priori","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.60.12.1081_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","article-title":"Anticardiolipin antibodies in Beh\u00e7et's disease: a reassessment.","volume":"40","author":"Tokay","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.60.12.1081_bib49","series-title":"Wintrobe's clinical haematology. Vol 2.","first-page":"1781","article-title":"Thrombosis and antithrombotic therapy.","author":"Rodgers","year":"1999"},{"key":"10.1136\/ard.60.12.1081_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2796.2000.00711.x","article-title":"Hyperhomocystinemia and activated protein C resistance in Beh\u00e7et's disease.","volume":"248","author":"Altinbas","year":"2000","journal-title":"J Intern Med"},{"key":"10.1136\/ard.60.12.1081_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3810\/pgm.2000.09.15.1236","article-title":"Evaluation of hypercoagulable state.","volume":"108","author":"Barger","year":"2000","journal-title":"Postgrad Med"},{"key":"10.1136\/ard.60.12.1081_bib52","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in 3'-untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1136\/ard.60.12.1081_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00062752-199809000-00006","article-title":"The prothrombin 20210 G to A variation and thrombosis.","volume":"5","author":"Bertina","year":"1998","journal-title":"Curr Opin Haematol"},{"key":"10.1136\/ard.60.12.1081_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-8652(199807)58:3<249::AID-AJH20>3.0.CO;2-3","article-title":"Prothrombin gene 20210 G - a mutation in the Turkish population.","volume":"58","author":"Akar","year":"1998","journal-title":"Am J Hematol"},{"key":"10.1136\/ard.60.12.1081_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1096-8652(199810)59:2<179::AID-AJH16>3.0.CO;2-4","article-title":"Prothrombin gene 20210 G - a mutation in Turkish patients with thrombosis.","volume":"59","author":"Gurgey","year":"1998","journal-title":"Am J Haematol"},{"key":"10.1136\/ard.60.12.1081_bib56","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/38.12.1298","article-title":"Procoagulant mutations and venous thrombosis in Beh\u00e7et's disease.","volume":"38","author":"Gul","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.60.12.1081_bib57","first-page":"2849","article-title":"Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutation on deep venous thrombogenesis in Beh\u00e7et's disease.","volume":"27","author":"Toydemir","year":"2000","journal-title":"J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724432998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724432998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.12.1081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:24:32Z","timestamp":1737264272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724432998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":57,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0003496724432998"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.12.1081","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beh\u00e7et's disease and thrombophilia","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.12.1081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}